Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analge… Read more
Sakar Healthcare Limited (SAKAR) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.101x
Based on the latest financial reports, Sakar Healthcare Limited (SAKAR) has a cash flow conversion efficiency ratio of 0.101x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹305.87 Million) by net assets (₹3.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sakar Healthcare Limited - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Sakar Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sakar Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sakar Healthcare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Risk George Inds A
PINK:RSKIA
|
0.021x |
|
Elementos Limited
F:9EM
|
-0.021x |
|
OnMobile Global Limited
NSE:ONMOBILE
|
0.086x |
|
Casing Macron Technology Co Ltd
TWO:3325
|
0.000x |
|
JCH Systems Inc
KQ:033320
|
0.126x |
|
PT Eagle High Plantations Tbk
F:7B7
|
0.034x |
|
RATH Aktiengesellschaft
VI:RAT
|
0.038x |
|
PharmaCorp Rx Inc.
V:PCRX
|
0.018x |
Annual Cash Flow Conversion Efficiency for Sakar Healthcare Limited (2010–2025)
The table below shows the annual cash flow conversion efficiency of Sakar Healthcare Limited from 2010 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹2.85 Billion | ₹340.32 Million | 0.119x | +27.82% |
| 2024-03-31 | ₹2.62 Billion | ₹244.67 Million | 0.093x | -54.22% |
| 2023-03-31 | ₹1.73 Billion | ₹353.14 Million | 0.204x | -27.26% |
| 2022-03-31 | ₹1.27 Billion | ₹356.99 Million | 0.280x | +89.16% |
| 2021-03-31 | ₹984.52 Million | ₹145.77 Million | 0.148x | +18.92% |
| 2020-03-31 | ₹813.20 Million | ₹101.25 Million | 0.125x | -53.27% |
| 2019-03-31 | ₹717.04 Million | ₹191.03 Million | 0.266x | +160.56% |
| 2018-03-31 | ₹514.93 Million | ₹52.65 Million | 0.102x | +18606825.53% |
| 2017-03-31 | ₹355.03 Million | ₹195.09 | 0.000x | -88.53% |
| 2016-03-31 | ₹191.82 Million | ₹918.64 | 0.000x | -100.00% |
| 2015-03-31 | ₹148.28 Million | ₹41.76 Million | 0.282x | -54.40% |
| 2014-03-31 | ₹138.71 Million | ₹85.67 Million | 0.618x | +13.02% |
| 2013-03-31 | ₹121.19 Million | ₹66.23 Million | 0.546x | +160.66% |
| 2012-03-31 | ₹137.59 Million | ₹28.84 Million | 0.210x | +1.82% |
| 2011-03-31 | ₹132.75 Million | ₹27.33 Million | 0.206x | +2334.89% |
| 2010-03-31 | ₹123.53 Million | ₹-1.14 Million | -0.009x | -- |